Millennium Management’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-6,800
Closed -$2.19M – 6295
2026
Q1
$2.19M Buy
6,800
+4,200
+162% +$1.3M ﹤0.01% 3791
2025
Q4
$766K Buy
+2,600
New +$484K ﹤0.01% 4661

Other funds holding PRAX

Millennium Management's PRAX Position: Q3 2026 in Review

Millennium Management increased its Praxis Precision Medicines (PRAX) stake by 638% in Q3 2026, buying an estimated $2.1M and bringing the position to 7,339 shares worth $2.14M. The position accounts for ﹤0.01% of the portfolio, ranked #3864.

Millennium Management first reported a position in PRAX in Q1 2021 and has held it in 20 quarters since. The position peaked at $11.6M in Q4 2024. 335 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

  • Millennium Management held 7,339 shares of Praxis Precision Medicines worth $2.14M as of Q3 2026.
  • Millennium Management bought 6,344 Praxis Precision Medicines shares in Q3 2026, an estimated $2.1M.
  • Praxis Precision Medicines made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #3864 holding.
  • Millennium Management first reported a position in Praxis Precision Medicines in Q1 2021 and has held it in 20 quarters since.
  • Millennium Management's Praxis Precision Medicines position peaked at $11.6M in Q4 2024.
  • 335 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.